Astrazeneca Pharmaceuticals LP
UnclaimedPharmaceutical Preparation ManufacturingWilmington, DE
Founded
1998
Primary NAICS
325412
CAGE code
36WK2
Federal awards
$632M
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- Pharmaceutical Preparation Manufacturing325412
Capabilities
Research and Development in Nanotechnology
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2026 | Department of Health and Human Services | $10,394,022 | 10 |
| 2026 | Department of Defense | $500 | 4 |
| 2026 | Department of Veterans Affairs | $0 | 30 |
| 2025 | Department of Health and Human Services | $8,991,990 | 14 |
| 2025 | Department of Defense | $500 | 4 |
| 2025 | Department of Veterans Affairs | $0 | 24 |
| 2024 | Department of Health and Human Services | $12,184,867 | 10 |
| 2024 | Department of Defense | $500 | 1 |
| 2024 | Department of Veterans Affairs | $0 | 36 |
| 2023 | Department of Health and Human Services | $12,090,211 | 8 |
| 2023 | Department of Veterans Affairs | $0 | 37 |
| 2023 | Department of Defense | -$33,297 | 3 |
| 2022 | Department of Defense | $575,889,601 | 8 |
| 2022 | Department of Health and Human Services | $12,528,308 | 5 |
| 2022 | Department of Veterans Affairs | $0 | 29 |